Enjoy complimentary customisation on priority with our Enterprise License!
Below are some of the key findings from the continuous subcutaneous insulin therapy devices market analysis report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Technological advances will trigger the growth of global continuous subcutaneous insulin therapy devices market during the forecast period. The high incidence of diabetes has increased the demand for diabetes management products such as CSITD in the market. So, the vendors of this market focus on developing innovative & better technologies. For instance, Medtronic utilizes advanced technologies like SmartGuard and Guardian Sensor 3 for developing their product. Guardian Sensor 3 technology is one of the most accurate technologies available for continuous glucose monitoring, whereas SmartGuard technology is the only available smart algorithm, which can adapt to fluctuating glucose levels and self-adjust insulin delivery. Thus, the growing demand of such technological advances will drive the growth of the global continuous subcutaneous insulin therapy devices market at a CAGR of over 9% during the forecast years.
The continuous subcutaneous insulin therapy devices market is moderately concentrated owing to the presence of several market players. These players are leveraging advanced technologies to offer high-quality products to meet the evolving needs of the end-user industries. By offering a complete analysis of the market’s competitive landscape and with information on the applications offered by the companies, this continuous subcutaneous insulin therapy devices industry analysis report will allow the clients to identify new growth opportunities and design innovative strategies for improving their share in the market.
The report offers a complete analysis of various companies including:
With a complete study of the growth opportunities for the companies across regions such as the Americas, APAC, and EMEA, our industry research analysts have estimated that countries in the Americas region will contribute to the highest growth of this market throughout the forecast period. The increasing incidence of diabetes has increased the demand of the continuous subcutaneous insulin therapy devices market in this region.
According to our market research experts, the tethered segment will account for the highest growth in the continuous subcutaneous insulin therapy devices market. Additionally, the report also provides an accurate prediction of the contribution of the various application segments to the growth of the continuous subcutaneous insulin therapy devices market size.
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 09: DRIVERS AND CHALLENGES
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
PART 12: VENDOR ANALYSIS
PART 13: APPENDIX
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.